1 B. Pathakumari, G. Liang, W. LiuImmune defence to invasive fungal infections: a comprehensive review Biomed Pharmacother, 130 (2020), p. 110550

2 S. Cassim, J. PouyssegurTumor microenvironment: a metabolic player that shapes the immune response Int J Mol Sci, 21 (1) (2019), p. 157

3 L. Sun, X. Wang, J. Saredy, Z. Yuan, X. Yang, H. WangInnate-adaptive immunity interplay and redox regulation in immune response Redox Biol, 37 (2020), p. 101759

4 L. Jiang, Y.J. Wang, J. Zhao, et al.Direct tumor killing and immunotherapy through anti-SerpinB9 therapy Cell, 183 (5) (2020), pp. 1219-1233

5 M. Nishino, N.H. Ramaiya, H. Hatabu, F.S. HodiMonitoring immune-checkpoint blockade: response evaluation and biomarker development Nat Rev Clin Oncol, 14 (11) (2017), pp. 655-668

6 R.D. Schreiber, L.J. Old, M.J. SmythCancer immunoediting: integrating immunity's roles in cancer suppression and promotion Science, 331 (6024) (2011), pp. 1565-1570

7 S.R. Paludan, L.S. Reinert, V. HornungDNA-stimulated cell death: implications for host defence, inflammatory diseases and cancer Nat Rev Immunol, 19 (3) (2019), pp. 141-153

8 I. Jorgensen, M. Rayamajhi, E.A. MiaoProgrammed cell death as a defence against infection Nat Rev Immunol, 17 (3) (2017), pp. 151-164

9 R. Tang, J. Xu, B. Zhang, et al.Ferroptosis, necroptosis, and pyroptosis in anticancer immunity J Hematol Oncol, 13 (1) (2020), p. 110

10 M.N. Messmer, A.G. Snyder, A. OberstComparing the effects of different cell death programs in tumor progression and immunotherapy Cell Death Differ, 26 (1) (2019), pp. 115-129

11 K. Hu, Z. Xu, L. Yao, Y. Yan, L. Zhou, J. LiIntegrated analysis of expression, prognostic value and immune infiltration of GSDMs in hepatocellular carcinoma Aging (Albany NY), 13 (21) (2021), pp. 24117-24135

12 J. Wei, Z. Xu, X. Chen, et al.Overexpression of GSDMC is a prognostic factor for predicting a poor outcome in lung adenocarcinoma Mol Med Rep, 21 (1) (2020), pp. 360-370

13 L. Liu, B. SunNeutrophil pyroptosis: new perspectives on sepsis Cell Mol Life Sci, 76 (11) (2019), pp. 2031-2042

14 Z. Zhang, Z. Xu, Y. YanRole of a pyroptosis-related lncRNA signature in risk stratification and immunotherapy of ovarian cancer Front Med (Lausanne), 8 (2022), p. 793515

15 R. Karki, T.D. KannegantiDiverging inflammasome signals in tumorigenesis and potential targeting Nat Rev Cancer, 19 (4) (2019), pp. 197-214

16 D.A. Erkes, W. Cai, I.M. Sanchez, et al.Mutant BRAF and MEK inhibitors regulate the tumor immune microenvironment via pyroptosis Cancer Discov, 10 (2) (2020), pp. 254-269

17 F. Xia, Y. Yan, C. ShenA prognostic pyroptosis-related lncRNAs risk model correlates with the immune microenvironment in colon adenocarcinoma Front Cell Dev Biol, 9 (2021), p. 811734

18 Z. Zhou, H. He, K. Wang, et al.Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells Science, 368 (6494) (2020), p. eaaz7548

19 S.K. Hsu, C.Y. Li, I.L. Lin, et al.Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment Theranostics, 11 (18) (2021), pp. 8813-8835

20 D. Chauhan, L. Vande Walle, M. LamkanfiTherapeutic modulation of inflammasome pathways Immunol Rev, 297 (1) (2020), pp. 123-138

21 Z. Xu, X. Wang, S. Zeng, X. Ren, Y. Yan, Z. GongApplying artificial intelligence for cancer immunotherapy Acta Pharm Sin B, 11 (11) (2021), pp. 3393-3405

22 Y. Yan, S. Zeng, Z. Gong, Z. XuClinical implication of cellular vaccine in glioma: current advances and future prospects J Exp Clin Cancer Res, 39 (1) (2020), p. 257

23 L. Zhang, Q.C. Yang, S. Wang, et al.Engineering multienzyme-mimicking covalent organic frameworks as pyroptosis inducers for boosting antitumor immunity Adv Mater, 34 (13) (2022), p. e2108174

24 B. Bai, Y. Yang, Q. Wang, et al.NLRP3 inflammasome in endothelial dysfunction Cell Death Dis, 11 (9) (2020), p. 776

25 Y. Xue, D. Enosi Tuipulotu, W.H. Tan, C. Kay, S.M. ManEmerging activators and regulators of inflammasomes and pyroptosis Trends Immunol, 40 (11) (2019), pp. 1035-1052

26 M. Lamkanfi, V.M. DixitInflammasomes and their roles in health and disease Annu Rev Cell Dev Biol, 28 (2012), pp. 137-161

27 S.K. Pachathundikandi, N. Blaser, H. Bruns, S. BackertHelicobacter pylori avoids the critical activation of NLRP3 inflammasome-mediated production of oncogenic mature IL-1β in human immune cells Cancers (Basel), 12 (4) (2020), p. 803

28 X. Zhang, C. Li, D. Chen, et al.H. pylori CagA activates the NLRP3 inflammasome to promote gastric cancer cell migration and invasion Inflamm Res, 71 (1) (2022), pp. 141-155

29 J. Huang, P. Fan, M. Liu, et al.Famotidine promotes inflammation by triggering cell pyroptosis in gastric cancer cells BMC Pharmacol Toxicol, 22 (1) (2021), p. 62

30 G.A. Ward, K.L. McGraw, F. Abbas-Aghababazadeh, et al.Oxidized mitochondrial DNA released after inflammasome activation is a disease biomarker for myelodysplastic syndromes Blood Adv, 5 (8) (2021), pp. 2216-2228

31 V.M. Ringel-Scaia, N. Beitel-White, M.F. Lorenzo, et al.High-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunity EBioMedicine, 44 (2019), pp. 112-125

32 R.E. KastInhibiting the NLRP3 inflammasome with methylene blue as treatment adjunct in myelodysplasia Front Oncol, 8 (2018), p. 280

33 D.A. Sallman, T. Cluzeau, A.A. Basiorka, A. ListUnraveling the pathogenesis of MDS: the NLRP3 inflammasome and pyroptosis drive the MDS phenotype Front Oncol, 6 (2016), p. 151

34 K.L. DeYoung, M.E. Ray, Y.A. Su, et al.Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma Oncogene, 15 (4) (1997), pp. 453-457

35 G. Patsos, A. Germann, J. Gebert, S. DihlmannRestoration of absent in melanoma 2 (AIM2) induces G2/M cell cycle arrest and promotes invasion of colorectal cancer cells Int J Cancer, 126 (8) (2010), pp. 1838-1849

36 S.M. Woerner, M. Kloor, Y. Schwitalle, et al.The putative tumor suppressor AIM2 is frequently affected by different genetic alterations in microsatellite unstable colon cancers Genes Chromosomes Cancer, 46 (12) (2007), pp. 1080-1089

37 M. Zhang, C. Jin, Y. Yang, et al.AIM2 promotes non-small-cell lung cancer cell growth through inflammasome-dependent pathway J Cell Physiol, 234 (11) (2019), pp. 20161-20173

38 T.L. Roberts, A. Idris, J.A. Dunn, et al.HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA Science, 323 (5917) (2009), pp. 1057-1060

39 V. Hornung, A. Ablasser, M. Charrel-Dennis, et al.AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC Nature, 458 (7237) (2009), pp. 514-518

40 T. Fernandes-Alnemri, J.W. Yu, P. Datta, J. Wu, E.S. AlnemriAIM2 activates the inflammasome and cell death in response to cytoplasmic DNA Nature, 458 (7237) (2009), pp. 509-513

41 T. Jin, A. Perry, J. Jiang, et al.Structures of the HIN domain:DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor Immunity, 36 (4) (2012), pp. 561-571

42 V.A. Rathinam, Z. Jiang, S.N. Waggoner, et al.The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses Nat Immunol, 11 (5) (2010), pp. 395-402

43 J.E. Wilson, A.S. Petrucelli, L. Chen, et al.Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt Nat Med, 21 (8) (2015), pp. 906-913

44 L. Corrales, S.R. Woo, J.B. Williams, S.M. McWhirter, T.W. Dubensky Jr., T.F. GajewskiAntagonism of the STING pathway via activation of the AIM2 inflammasome by intracellular DNA J Immunol, 196 (7) (2016), pp. 3191-3198

45 D. So, H.W. Shin, J. Kim, et al.Cervical cancer is addicted to SIRT1 disarming the AIM2 antiviral defense Oncogene, 37 (38) (2018), pp. 5191-5204

46 C.E. Vrentas, P.M. Boggiatto, S.C. Olsen, S.H. Leppla, M. MoayeriCharacterization of the NLRP1 inflammasome response in bovine species Innate Immun, 26 (4) (2020), pp. 301-311

47 D.C. Johnson, M.C. Okondo, E.L. Orth, et al.DPP8/9 inhibitors activate the CARD8 inflammasome in resting lymphocytes Cell Death Dis, 11 (8) (2020), p. 628

48 A.R. Griswold, H.C. Huang, D.A. BachovchinThe NLRP1 inflammasome induces pyroptosis in human corneal epithelial cells Invest Ophthalmol Vis Sci, 63 (3) (2022), p. 2

49 L. Ghimire, S. Paudel, L. Jin, P. Baral, S. Cai, S. JeyaseelanNLRP6 negatively regulates pulmonary host defense in Gram-positive bacterial infection through modulating neutrophil recruitment and function PLoS Pathog, 14 (9) (2018), p. e1007308

50 W. Liu, J. Liu, W. Wang, Y. Wang, X. OuyangNLRP6 induces pyroptosis by activation of caspase-1 in gingival fibroblasts J Dent Res, 97 (12) (2018), pp. 1391-1398

51 N. Naseer, M.S. Egan, V.M. Reyes Ruiz, et al.Human NAIP/NLRC4 and NLRP3 inflammasomes detect Salmonella type III secretion system activities to restrict intracellular bacterial replication PLoS Pathog, 18 (1) (2022), p. e1009718

52 S. Zhu, S. Ding, P. Wang, et al.Nlrp9b inflammasome restricts rotavirus infection in intestinal epithelial cells Nature, 546 (7660) (2017), pp. 667-670

53 J. Shi, Y. Zhao, K. Wang, et al.Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death Nature, 526 (7575) (2015), pp. 660-665

54 N. Van Opdenbosch, M. LamkanfiCaspases in cell death, inflammation, and disease Immunity, 50 (6) (2019), pp. 1352-1364

55 N.A. Thornberry, H.G. Bull, J.R. Calaycay, et al.A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes Nature, 356 (6372) (1992), pp. 768-774

56 S.M. Gaikwad, Z. Phyo, A.Q. Arteaga, et al.A small molecule stabilizer of the MYC G4-quadruplex induces endoplasmic reticulum stress, senescence and pyroptosis in multiple myeloma Cancers (Basel), 12 (10) (2020), p. 2952

57 M.M. Nyiramana, S.B. Cho, E.J. Kim, et al.Sea hare hydrolysate-induced reduction of human non-small cell lung cancer cell growth through regulation of macrophage polarization and non-apoptotic regulated cell death pathways Cancers (Basel), 12 (3) (2020), p. 726

58 Y. Song, X. Wu, Y. Xu, et al.HPV E7 inhibits cell pyroptosis by promoting TRIM21-mediated degradation and ubiquitination of the IFI16 inflammasome Int J Biol Sci, 16 (15) (2020), pp. 2924-2937

59 A. Takasu, A. Masui, M. Hamada, T. Imai, S. Iwai, Y. YuraImmunogenic cell death by oncolytic herpes simplex virus type 1 in squamous cell carcinoma cells Cancer Gene Ther, 23 (4) (2016), pp. 107-113

60 T. Arakelian, K. Oosterhuis, E. Tondini, et al.Pyroptosis-inducing active caspase-1 as a genetic adjuvant in anti-cancer DNA vaccination Vaccine, 40 (13) (2022), pp. 2087-2098

61 J. Shi, Y. Zhao, Y. Wang, et al.Inflammatory caspases are innate immune receptors for intracellular LPS Nature, 514 (7521) (2014), pp. 187-192

62 S. Yokoyama, S. Nakayama, L. Xu, A.L. Pilon, S. KimuraSecretoglobin 3A2 eliminates human cancer cells through pyroptosis Cell Death Discov, 7 (1) (2021), p. 12

63 Y. Jiao, L. Wang, L. Lu, et al.The role of caspase-4 and NLRP1 in MCF7 cell pyroptosis induced by hUCMSC-secreted factors Stem Cells Int, 2020 (2020), p. 8867115

64 T. Ishii, H. Hayakawa, T. Sekiguchi, N. Adachi, M. SekiguchiRole of Auf1 in elimination of oxidatively damaged messenger RNA in human cells Free Radic Biol Med, 79 (2015), pp. 109-116

65 N. Kayagaki, I.B. Stowe, B.L. Lee, et al.Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling Nature, 526 (7575) (2015), pp. 666-671

66 W.T. He, H. Wan, L. Hu, et al.Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion Cell Res, 25 (12) (2015), pp. 1285-1298

67 N. Rana, G. Privitera, H.C. Kondolf, et al.GSDMB is increased in IBD and regulates epithelial restitution/repair independent of pyroptosis Cell, 185 (2) (2022), pp. 283-298

68 W. Deng, Y. Bai, F. Deng, et al.Streptococcal pyrogenic exotoxin B cleaves GSDMA and triggers pyroptosis Nature, 602 (7897) (2022), pp. 496-502

69 Z. Zheng, W. Deng, Y. Bai, et al.The lysosomal rag-ragulator complex licenses RIPK1 and caspase-8-mediated pyroptosis by Yersinia Science, 372 (6549) (2021), p. eabg0269

70 C.L. Evavold, I. Hafner-Bratkovič, P. Devant, et al.Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathway Cell, 184 (17) (2021), pp. 4495-4511

71 S. Xia, Z. Zhang, V.G. Magupalli, et al.Gasdermin D pore structure reveals preferential release of mature interleukin-1 Nature, 593 (7860) (2021), pp. 607-611

72 P. Broz, P. Pelegrín, F. ShaoThe gasdermins, a protein family executing cell death and inflammation Nat Rev Immunol, 20 (3) (2020), pp. 143-157

73 J. Ding, K. Wang, W. Liu, et al.Pore-forming activity and structural autoinhibition of the gasdermin family Nature, 535 (7610) (2016), pp. 111-116

74 R.A. Aglietti, A. Estevez, A. Gupta, et al.GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes Proc Natl Acad Sci U S A, 113 (28) (2016), pp. 7858-7863

75 X. Chen, W.T. He, L. Hu, et al.Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis Cell Res, 26 (9) (2016), pp. 1007-1020

76 X. Liu, Z. Zhang, J. Ruan, et al.Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores Nature, 535 (7610) (2016), pp. 153-158

77 L. Sborgi, S. Rühl, E. Mulvihill, et al.GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death EMBO J, 35 (16) (2016), pp. 1766-1778

78 K. Wang, Q. Sun, X. Zhong, et al.Structural mechanism for GSDMD targeting by autoprocessed caspases in pyroptosis Cell, 180 (5) (2020), pp. 941-955

79 K.C. Barnett, J.P. TingMitochondrial GSDMD pores DAMPen pyroptosis Immunity, 52 (3) (2020), pp. 424-426

80 Z. Liu, L. Gan, Y. Xu, et al.Melatonin alleviates inflammasome-induced pyroptosis through inhibiting NF-κB/GSDMD signal in mice adipose tissue J Pineal Res, 63 (1) (2017), p. e12414

81 M.C. Okondo, D.C. Johnson, R. Sridharan, et al.DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis Nat Chem Biol, 13 (1) (2017), pp. 46-53

82 M.C. Okondo, S.D. Rao, C.Y. Taabazuing, et al.Inhibition of Dpp8/9 activates the Nlrp1b inflammasome Cell Chem Biol, 25 (3) (2018), pp. 262-267

83 C.Y. Taabazuing, M.C. Okondo, D.A. BachovchinPyroptosis and apoptosis pathways engage in bidirectional crosstalk in monocytes and macrophages Cell Chem Biol, 24 (4) (2017), pp. 507-514

84 L. Van Laer, E.H. Huizing, M. Verstreken, et al.Nonsyndromic hearing impairment is associated with a mutation in DFNA5 Nat Genet, 20 (2) (1998), pp. 194-197

85 Z. Zhang, Y. Zhang, S. Xia, et al.Gasdermin E suppresses tumour growth by activating anti-tumour immunity Nature, 579 (7799) (2020), pp. 415-420

86 M. Guo, Z.D. Xiao, Z. Dai, et al.The landscape of long noncoding RNA-involved and tumor-specific fusions across various cancers Nucleic Acids Res, 48 (22) (2020), pp. 12618-12631

87 P. Zhao, M. Wang, M. Chen, et al.Programming cell pyroptosis with biomimetic nanoparticles for solid tumor immunotherapy Biomaterials, 254 (2020), p. 120142

88 J. Yu, S. Li, J. Qi, et al.Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells Cell Death Dis, 10 (3) (2019), p. 193

89 Q. Ding, W. Zhang, C. Cheng, et al.Dioscin inhibits the growth of human osteosarcoma by inducing G2/M-phase arrest, apoptosis, and GSDME-dependent cell death in vitro and in vivo J Cell Physiol, 235 (3) (2020), pp. 2911-2924

90 J. Hu, W. Pei, M. Jiang, et al.DFNA5 regulates immune cells infiltration and exhaustion Cancer Cell Int, 22 (1) (2022), p. 107

91 S. Wang, M.J. Zhang, Z.Z. Wu, et al.GSDME is related to prognosis and response to chemotherapy in oral cancer J Dent Res, 101 (7) (2022), pp. 848-858

92 K. Akino, M. Toyota, H. Suzuki, et al.Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer Cancer Sci, 98 (1) (2007), pp. 88-95

93 A. Liu, L. Shen, N. Li, L. Shen, Z. LiPan-cancer analyses of pyroptosis with functional implications for prognosis and immunotherapy in cancer J Transl Med, 20 (1) (2022), p. 109

94 G. Tan, C. Lin, C. Huang, et al.Radiosensitivity of colorectal cancer and radiation-induced gut damages are regulated by gasdermin E Cancer Lett, 529 (2022), pp. 1-10

95 F. Su, J. Duan, J. Zhu, H. Fu, X. Zheng, C. GeLong non-coding RNA nuclear paraspeckle assembly transcript 1 regulates ionizing radiation-induced pyroptosis via microRNA-448/gasdermin E in colorectal cancer cells Int J Oncol, 59 (4) (2021), p. 79

96 J. Hou, R. Zhao, W. Xia, et al.PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis Nat Cell Biol, 22 (10) (2020), pp. 1264-1275

97 C. Berkel, E. CacanDifferential expression and copy number variation of gasdermin (GSDM) family members, pore-forming proteins in pyroptosis, in normal and malignant serous ovarian tissue Inflammation, 44 (6) (2021), pp. 2203-2216

98 D.L. Elion, M.E. Jacobson, D.J. Hicks, et al.Therapeutically active RIG-I agonist induces immunogenic tumor cell killing in breast cancers Cancer Res, 78 (21) (2018), pp. 6183-6195

99 Q. Yu, M. Zhang, Q. Ying, et al.Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment Cell Death Dis, 10 (3) (2019), p. 218

100 T. Zhang, D.M. Wu, P.W. Luo, et al.CircNEIL3 mediates pyroptosis to influence lung adenocarcinoma radiotherapy by upregulating PIF1 through miR-1184 inhibition Cell Death Dis, 13 (2) (2022), p. 167

101 S.L. Chen, L.L. Liu, S.X. Lu, et al.HBx-mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis Mol Oncol, 11 (9) (2017), pp. 1225-1240

102 D. Zhivaki, J.C. KaganNLRP3 inflammasomes that induce antitumor immunity Trends Immunol, 42 (7) (2021), pp. 575-589

103 L. Li, M. Jiang, L. Qi, et al.Pyroptosis, a new bridge to tumor immunity Cancer Sci, 112 (10) (2021), pp. 3979-3994

104 P. Yu, X. Zhang, N. Liu, L. Tang, C. Peng, X. ChenPyroptosis: mechanisms and diseases Signal Transduct Target Ther, 6 (1) (2021), p. 128

105 Y. Xiao, T. Zhang, X. Ma, et al.Microenvironment-responsive prodrug-induced pyroptosis boosts cancer immunotherapy Adv Sci (Weinh), 8 (24) (2021), p. e2101840

106 Z. Qian, Y. Zhao, C. Wan, et al.Pyroptosis in the initiation and progression of atherosclerosis Front Pharmacol, 12 (2021), p. 652963

107 S. An, H. Hu, Y. Li, Y. HuPyroptosis plays a role in osteoarthritis Aging Dis, 11 (5) (2020), pp. 1146-1157

108 J. Wu, S. Lin, B. Wan, B. Velani, Y. ZhuPyroptosis in liver disease: new insights into disease mechanisms Aging Dis, 10 (5) (2019), pp. 1094-1108

109 J. Lin, A. Cheng, K. Cheng, et al.New insights into the mechanisms of pyroptosis and implications for diabetic kidney disease Int J Mol Sci, 21 (19) (2020), p. 7057

110 X. Lu, T. Guo, X. ZhangPyroptosis in cancer: friend or foe? Cancers (Basel), 13 (14) (2021), p. 3620

111 L. Yao, J. Li, Z. Xu, Y. Yan, K. HuGSDMs are potential therapeutic targets and prognostic biomarkers in clear cell renal cell carcinoma Aging (Albany NY), 14 (6) (2022), pp. 2758-2774

112 G. Lin, Q. Feng, F. Zhan, F. Yang, Y. Niu, G. LiGeneration and analysis of pyroptosis-based and immune-based signatures for kidney renal clear cell carcinoma patients, and cell experiment Front Genet, 13 (2022), p. 809794

113 Y.F. Tan, M. Wang, Z.Y. Chen, L. Wang, X.H. LiuInhibition of BRD4 prevents proliferation and epithelial-mesenchymal transition in renal cell carcinoma via NLRP3 inflammasome-induced pyroptosis Cell Death Dis, 11 (4) (2020), p. 239

114 X. Zhang, P. Zhang, L. An, et al.Miltirone induces cell death in hepatocellular carcinoma cell through GSDME-dependent pyroptosis Acta Pharm Sin B, 10 (8) (2020), pp. 1397-1413

115 D.C. Johnson, C.Y. Taabazuing, M.C. Okondo, et al.DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia Nat Med, 24 (8) (2018), pp. 1151-1156

116 C.B. Zhou, J.Y. FangThe role of pyroptosis in gastrointestinal cancer and immune responses to intestinal microbial infection Biochim Biophys Acta Rev Cancer, 1872 (1) (2019), pp. 1-10

117 F. Awad, E. Assrawi, C. Jumeau, et al.Impact of human monocyte and macrophage polarization on NLR expression and NLRP3 inflammasome activation PLoS One, 12 (4) (2017), p. e0175336

118 Y. Jiao, T. Zhang, C. Zhang, et al.Exosomal miR-30d-5p of neutrophils induces M1 macrophage polarization and primes macrophage pyroptosis in sepsis-related acute lung injury Crit Care, 25 (1) (2021), p. 356

119 A. Mónaco, S. Chilibroste, L. Yim, J.A. Chabalgoity, M. MorenoInflammasome activation, NLRP3 engagement and macrophage recruitment to tumor microenvironment are all required for Salmonella antitumor effect Cancer Immunol Immunother, 71 (9) (2022), pp. 2141-2150

120 F.Y. Mai, P. He, J.Z. Ye, et al.Caspase-3-mediated GSDME activation contributes to cisplatin- and doxorubicin-induced secondary necrosis in mouse macrophages Cell Prolif, 52 (5) (2019), p. e12663

121 S. GhoshCisplatin: the first metal based anticancer drug Bioorg Chem, 88 (2019), p. 102925

122 D. Chen, S. Guo, X. Tang, et al.Combination of ruthenium (II) polypyridyl complex Δ-Ru1 and Taxol enhances the anti-cancer effect on Taxol-resistant cancer cells through Caspase-1/GSDMD-mediated pyroptosis J Inorg Biochem, 230 (2022), p. 111749

123 E. Yue, G. Tuguzbaeva, X. Chen, et al.Anthocyanin is involved in the activation of pyroptosis in oral squamous cell carcinoma Phytomedicine, 56 (2019), pp. 286-294

124 X. Shen, H. Wang, C. Weng, H. Jiang, J. ChenCaspase 3/GSDME-dependent pyroptosis contributes to chemotherapy drug-induced nephrotoxicity Cell Death Dis, 12 (2) (2021), p. 186

125 Z. Huang, Q. Zhang, Y. Wang, et al.Inhibition of caspase-3-mediated GSDME-derived pyroptosis aids in noncancerous tissue protection of squamous cell carcinoma patients during cisplatin-based chemotherapy Am J Cancer Res, 10 (12) (2020), pp. 4287-4307

126 Z. Cheng, Z. Li, L. Gu, et al.Ophiopogonin B alleviates cisplatin resistance of lung cancer cells by inducing Caspase-1/GSDMD dependent pyroptosis J Cancer, 13 (2) (2022), pp. 715-727

127 Y. Wang, W. Gao, X. Shi, et al.Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin Nature, 547 (7661) (2017), pp. 99-103

128 B. Pulendran, M.M. DavisThe science and medicine of human immunology Science, 369 (6511) (2020), p. eaay4014

129 K. TsuchiyaSwitching from apoptosis to pyroptosis: gasdermin-elicited inflammation and antitumor immunity Int J Mol Sci, 22 (1) (2021), p. 426

130 P. Orning, E. Lien, K.A. FitzgeraldGasdermins and their role in immunity and inflammation J Exp Med, 216 (11) (2019), pp. 2453-2465

131 S. Hamarsheh, R. ZeiserNLRP3 inflammasome activation in cancer: a double-edged sword Front Immunol, 11 (2020), p. 1444

132 D. Zhivaki, F. Borriello, O.A. Chow, et al.Inflammasomes within hyperactive murine dendritic cells stimulate long-lived T cell-mediated anti-tumor immunity Cell Rep, 33 (7) (2020), p. 108381

133 C. Hage, S. Hoves, L. Strauss, et al.Sorafenib induces pyroptosis in macrophages and triggers natural killer cell-mediated cytotoxicity against hepatocellular carcinoma Hepatology, 70 (4) (2019), pp. 1280-1297